Reith Sebastian, Zhang Ying, Bach Christoper, Deschka Heinz
Dtsch Med Wochenschr. 2022 Aug;147(16):1039-1047. doi: 10.1055/a-1639-9337. Epub 2022 Aug 15.
The management of severe symptomatic mitral regurgitation is in contrast to the aortic-valve-intervention more challenging due to the complex mitral-valve anatomy. In primary mitral regurgitation surgical therapy is recommended, whereas there are various therapeutic options in secondary mitral regurgitation. Besides the established mitral-valve Transcatheter Edge-to-Edge-Repair (M-TEER) and the interventional annuloplasty - devices dynamic developments have recently been made in the field of Transcatheter Mitral Valve Replacement-therapy (TMVR). This article surveys the current recommendations and available therapeutic options in mitral regurgitation.
由于二尖瓣解剖结构复杂，重度有症状二尖瓣反流的管理相较于主动脉瓣干预更具挑战性。在原发性二尖瓣反流中，推荐手术治疗，而继发性二尖瓣反流有多种治疗选择。除了已有的二尖瓣经导管缘对缘修复术（M-TEER）和介入性瓣环成形术——设备外，经导管二尖瓣置换术（TMVR）领域最近也有动态发展。本文概述了二尖瓣反流的当前推荐和可用治疗选择。
